Chapter Ten - Kinetic characterization of methylthio-d-ribose-1-phosphate isomerase

Autor: Veeramachineni, Vamsee M., Ubayawardhana, Subashi T., Murkin, Andrew S.

Publikováno v: In Methods in Enzymology 2023 685:279-318

Discovery of PF-06928215 as a high affinity inhibitor of cGAS enabled by a novel fluorescence polarization assay.

Autor: Hall J; Medicine Design, Pfizer, Groton, Connecticut, United States of America., Brault A; Medicine Design, Pfizer, Groton, Connecticut, United States of America., Vincent F; Medicine Design, Pfizer, Groton, Connecticut, United States of America., Weng S; Pfizer Centers for Therapeutic Innovation (CTI), Boston, Massachusetts, United States of America., Wang H; Medicine Design, Pfizer, Groton, Connecticut, United States of America., Dumlao D; Medicine Design, Pfizer, Groton, Connecticut, United States of America., Aulabaugh A; Medicine Design, Pfizer, Groton, Connecticut, United States of America., Aivazian D; Pfizer Centers for Therapeutic Innovation (CTI), San Diego, California, United States of America., Castro D; Pfizer Centers for Therapeutic Innovation (CTI), San Diego, California, United States of America., Chen M; Medicine Design, Pfizer, Groton, Connecticut, United States of America., Culp J; Medicine Design, Pfizer, Groton, Connecticut, United States of America., Dower K; Inflammation and Immunology, Pfizer, Cambridge, Massachusetts, United States of America., Gardner J; External Research Solutions, Pfizer, Groton, Connecticut, United States of America., Hawrylik S; Medicine Design, Pfizer, Groton, Connecticut, United States of America., Golenbock D; University of Massachusetts Medical School, Worcester, Massachusetts, United States of America., Hepworth D; Medicine Design, Pfizer, Cambridge, Massachusetts, United States of America., Horn M; Pfizer Centers for Therapeutic Innovation (CTI), San Diego, California, United States of America., Jones L; Medicine Design, Pfizer, Cambridge, Massachusetts, United States of America., Jones P; Medicine Design, Pfizer, Cambridge, Massachusetts, United States of America., Latz E; University of Massachusetts Medical School, Worcester, Massachusetts, United States of America.; Institute of Innate Immunity, University Hospitals Bonn, Bonn, Germany., Li J; Medicine Design, Pfizer, Cambridge, Massachusetts, United States of America., Lin LL; Inflammation and Immunology, Pfizer, Cambridge, Massachusetts, United States of America., Lin W; Medicine Design, Pfizer, Groton, Connecticut, United States of America., Lin D; Medicine Design, Pfizer, Groton, Connecticut, United States of America., Lovering F; Medicine Design, Pfizer, Cambridge, Massachusetts, United States of America., Niljanskul N; Medicine Design, Pfizer, Groton, Connecticut, United States of America., Nistler R; Pfizer Centers for Therapeutic Innovation (CTI), Boston, Massachusetts, United States of America., Pierce B; Medicine Design, Pfizer, Groton, Connecticut, United States of America., Plotnikova O; Medicine Design, Pfizer, Groton, Connecticut, United States of America., Schmitt D; Medicine Design, Pfizer, Groton, Connecticut, United States of America., Shanker S; Medicine Design, Pfizer, Groton, Connecticut, United States of America., Smith J; Medicine Design, Pfizer, Groton, Connecticut, United States of America., Snyder W; Pfizer Centers for Therapeutic Innovation (CTI), San Diego, California, United States of America., Subashi T; Medicine Design, Pfizer, Groton, Connecticut, United States of America., Trujillo J; Medicine Design, Pfizer, Groton, Connecticut, United States of America., Tyminski E; Pfizer Centers for Therapeutic Innovation (CTI), Boston, Massachusetts, United States of America., Wang G; Pfizer Centers for Therapeutic Innovation (CTI), Boston, Massachusetts, United States of America., Wong J; Medicine Design, Pfizer, Groton, Connecticut, United States of America., Lefker B; Medicine Design, Pfizer, Cambridge, Massachusetts, United States of America., Dakin L; Medicine Design, Pfizer, Cambridge, Massachusetts, United States of America., Leach K; Pfizer Centers for Therapeutic Innovation (CTI), Boston, Massachusetts, United States of America.

Publikováno v: PloS one [PLoS One] 2017 Sep 21; Vol. 12 (9), pp. e0184843. Date of Electronic Publication: 2017 Sep 21 (Print Publication: 2017).

Simple spectrophotometric assay for measuring protein binding of penem antibiotics to human serum

Autor: Gootz, T D, Subashi, T A, Lindner, D L

Publikováno v: Antimicrobial Agents and Chemotherapy; February 1988, Vol. 32 Issue: 2 p159-163, 5p

Molecular evolutionary insight of structural zinc atom in yeast xylitol dehydrogenases and its application in bioethanol production by lignocellulosic biomass.

Autor: Yoshiwara, Kentaroh¹ (AUTHOR), Watanabe, Seiya^1,2,3 (AUTHOR) irab@agr.ehime-u.ac.jp, Watanabe, Yasunori⁴ (AUTHOR)

Publikováno v: Scientific Reports. 2/4/2023, Vol. 13 Issue 1, p1-14. 14p.

Biofilm producing plant growth promoting bacteria in combination with glycine betaine uplift drought stress tolerance of maize plant.

Autor: Yasmeen, Tahira, Arif, Muhammad Saleem, Tariq, Mohsin, Akhtar, Sadia, Syrish, Afira, Haidar, Waqas, Rizwan, Muhammad, Hussain, Muhammad Iftikhar, Ahmad, Ajaz, Ali, Shafaqat

Publikováno v: Frontiers in Plant Science; 2024, p1-16, 16p